Successful Phase 2 Clinical Trial Results with Novel Influenza Vaccine Validate SGS’s H3N2 Challenge Agent (A/Belgium)
Antwerp, Belgium March 12, 2019: SGS, a leading life-sciences, clinical and bioanalytical contract solutions provider, today welcomed the preliminary data from ...


